Episodes

  • New Guidelines for the Assessment of Traumatic Brain Injury

    New Guidelines for the Assessment of Traumatic Brain Injury
    May 7 2025
    Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, University of Pittsburgh, Pittsburg, PA, describe some of the important updates to guidelines for the assessment of traumatic brain injury, including biomarker testing.
    Show More Show Less
    21 mins
  • The Impact of High Efficacy DMTs on Paramagnetic Rim Lesions

    The Impact of High Efficacy DMTs on Paramagnetic Rim Lesions
    Mar 22 2025
    Jack Reeves, PhD, researcher at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, discusses results of a study which demonstrated high efficacy disease-modifying therapies may help prevent the development of paramagnetic rim lesions and slow the progression of multiple sclerosis.
    Show More Show Less
    14 mins
  • Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm

    Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm
    Mar 14 2025
    Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagnosis. Peter Pronovost, MD, PhD, FCCM, Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, Cleveland, OH, discusses his work with the Parkinson’s Foundation developing new hospital care standards for reducing medication mismanagement and improper or insufficient care.
    Show More Show Less
    15 mins
  • Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

    Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome
    Jan 22 2025
    Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational treatment for individuals with Dravet syndrome, including outcomes related to seizure frequency, cognition, and behavior.
    Show More Show Less
    18 mins
  • Vagus Nerve Stimulation: Effects Beyond the Nervous System

    Vagus Nerve Stimulation: Effects Beyond the Nervous System
    Dec 19 2024
    Stavros Zanos, MD, PhD, Associate Professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, uses neurostimulation as a means to study the nervous system and to treat diseases in which the nervous system is affected or implicated. In this episode, Dr. Zanos gives an overview of the current understanding of Vagus Nerve Stimulation and shares important updates for future research and treatments beyond the nervous system.
    Show More Show Less
    29 mins
  • The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions

    The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions
    Nov 20 2024
    Paul Kruszka, MD, Chief Medical Officer at GeneDx, discusses advanced genomic testing, emphasizing how these tests are used to guide diagnosis and treatment decisions associated with neurodevelopmental conditions, including genetic variants associated with epilepsy.
    Show More Show Less
    14 mins
  • Physicians with Substance Use Disorder, Part II: Available Treatment and Recovery Options

    Physicians with Substance Use Disorder, Part II: Available Treatment and Recovery Options
    Mar 21 2024
    Chris Bundy, MD, Executive Medical Director, Washington Physicians Health Program, provides an overview of treatment and recovery options available to physicians with substance use disorder, including peer-to-peer support, medication, and Physician Health Programs.
    Show More Show Less
    7 mins
  • Physicians with Substance Use Disorder, Part I: Overview and A Personal Journey Through Recovery

    Physicians with Substance Use Disorder, Part I: Overview and A Personal Journey Through Recovery
    Mar 8 2024
    Chris Bundy, MD, Executive Medical Director, Washington Physicians Health Program, provides an overview of physician substance use disorder, including prevalence, risk factors, and impediments to recovery as well as details about his own journey with recovery.
    Show More Show Less
    11 mins